Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PX-866 in Recurrent Glioblastoma
NCT01259869Phase 2Completed
- Sponsor
- Canadian Cancer Trials Group
- Start
- Apr 2011
- Primary completion
- Oct 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of sonolisib in glioblastoma multiforme (GBM), sponsored by Canadian Cancer Trials Group. Started Apr 2011; status: completed.
02
Drugs
sonolisib
03
Conditions
glioblastoma multiforme (GBM)
Beyond the preview
Go deeper on NCT01259869.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01259869.